18h
Zacks Investment Research on MSNTempus AI Surges 40% YTD: Are New Strategic Deals a Buy Signal?Artificial Intelligence (AI)-based healthcare solutions company Tempus AI TEM has continued to capture investors’ attention despite reporting weaker-than-expected fourth-quarter 2024 results on Feb.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results